<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02309905</url>
  </required_header>
  <id_info>
    <org_study_id>Teledermatology for Inmates</org_study_id>
    <nct_id>NCT02309905</nct_id>
  </id_info>
  <brief_title>Evaluation of Tele-expertise for Inmates With a Dermatological Lesion</brief_title>
  <acronym>TLM-Inmates</acronym>
  <official_title>Evaluation of Tele-expertise for Inmates With a Dermatological Lesion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agence Regionale de Sante d'Ile de France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Tele-expertise would be effective and
      cost-effective by reducing the number of secure transportations for inmates in need of a
      dermatological consultation
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of a dermatological expertise among those required</measure>
    <time_frame>1 month after the end of the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalizations for a dermatological reason</measure>
    <time_frame>1 month after the end of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall costs</measure>
    <time_frame>6 months after the end of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to a dermatological expertise</measure>
    <time_frame>1 month after the end of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of usual consultations needed after Tele-expertise</measure>
    <time_frame>1 month after the end of the study</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Skin Disease</condition>
  <arm_group>
    <arm_group_label>Control group before telemedicine</arm_group_label>
    <description>Inmates of prisons not having telemedicine before implementation of telemedicine in prisons having telemedicine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group after telemedicine</arm_group_label>
    <description>Inmates of prisons not having telemedicine after implementation of telemedicine in prisons having telemedicine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exposed group, before telemedicine</arm_group_label>
    <description>Inmates of prisons having telemedicine before implementation of telemedicine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exposed group, after telemedicine</arm_group_label>
    <description>Inmates of prisons having telemedicine after implementation of telemedicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemedicine</intervention_name>
    <description>Inmates of prisons having telemedicine after implementation of telemedicine</description>
    <arm_group_label>Exposed group, after telemedicine</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Inmates
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dermatological expertise required

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Moreau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle Durand-Zaleski, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>DRCD URC Eco. Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSA Osny</name>
      <address>
        <city>Cergy-Pontoise</city>
        <zip>95524</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSA Meaux</name>
      <address>
        <city>Meaux</city>
        <zip>77351</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSA Nanterre</name>
      <address>
        <city>Nanterre</city>
        <zip>92014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSA Réau</name>
      <address>
        <city>Réau</city>
        <zip>77550</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSA Villepinte</name>
      <address>
        <city>Villepinte</city>
        <zip>93420</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.renewinghealth.eu/assessment-method</url>
  </link>
  <reference>
    <citation>Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.</citation>
    <PMID>22617736</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2014</study_first_submitted>
  <study_first_submitted_qc>December 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2014</study_first_posted>
  <last_update_submitted>January 14, 2016</last_update_submitted>
  <last_update_submitted_qc>January 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>inmates</keyword>
  <keyword>skin lesion</keyword>
  <keyword>telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatologic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

